Announcements Trials

Browse Landscape

Phase

Phase 1/2 2 Phase EARLY_PHASE1 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 73 Neoplasms 46 Squamous Cell Carcinoma of Head and Neck 45 Head and Neck Neoplasms 35 Lung Neoplasms 34 Uterine Cervical Neoplasms 27 Neoplasm Metastasis 26 Unspecified Adult Solid Tumor, Protocol Specific 24 Stomach Neoplasms 24 Ovarian Neoplasms 24 Small Cell Lung Carcinoma 21 Pancreatic Neoplasms 19 Colorectal Neoplasms 18 Cholangiocarcinoma 17 Carcinoma, Squamous Cell 17 Esophageal Neoplasms 16 Breast Neoplasms 15 Mesothelioma, Malignant 14 Melanoma 13 Urinary Bladder Neoplasms 12 Mesothelioma 11 Fallopian Tube Neoplasms 11 Carcinoma, Ovarian Epithelial 11 Sarcoma 9 Gallbladder Neoplasms 9 Esophageal Squamous Cell Carcinoma 9 Biliary Tract Neoplasms 9 Carcinoma 8 Triple Negative Breast Neoplasms 7 Recurrence 7

Interventions

Cyclophosphamide 38 fludarabine 30 Rituximab 26 obinutuzumab 10 Bendamustine Hydrochloride 10 fludarabine phosphate 9 pembrolizumab 8 Specimen Handling 7 Etoposide 7 venetoclax 6 Vincristine 6 Prednisone 6 Magnetic Resonance Spectroscopy 6 Leukapheresis 6 Lenalidomide 6 ibrutinib 5 Inotuzumab Ozogamicin 5 Immunotherapy, Adoptive 5 Doxorubicin 5 Biopsy 5 ublituximab 4 tazemetostat 4 glofitamab 4 Interleukin-2 4 Dexamethasone 4 Cytarabine 4 pomalidomide 3 polatuzumab vedotin 3 Radiation 3 Nivolumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Lymphoma, B-Cell × Cisplatin × Clear all

NCT02741388 2021-12-07

SELINDA

The Lymphoma Academic Research Organisation

Phase 1 Completed

Lymphoma, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡